1. Drugs Directorate Policy: CI Standard for Comparative Bioavailability,1991
2. Guidance: Investigation of Bioavailability and Bioequivalence,1992
3. Guidance on Statistical Procedures for Bioequivalence Studies Using a Standard Two-Treatment Crossover Design, informal communication by the Division of Bioequivalence,1992
4. Bioequivalence requirements for generic products
5. Biopharmaceutical Statistics for Drug Development;Westlake,1988